GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Kosan Biosciences Incorporated (KOSN) [hlAlert]

Rating:
Buy KOSN
up 12.82 %

Kosan Biosciences Incorporated (KOSN) rated Buy with price target $5 by Needham & Co

Posted on: Monday,  Mar 3, 2008  8:25 AM ET by Needham

Needham rated Buy Kosan Biosciences Incorporated (KOSN) on 03/03/2008. Previously Needham rated Buy Kosan Biosciences Incorporated (KOSN) on 12/03/2007., when
the stock price was $4.99. Since then, Kosan Biosciences Incorporated has gained 12.83% as of 09/25/2008's recent price of $5.63.
If you would have followed the previous Needham's recommendation on KOSN, you would have gained 12.82% of your investment in 297 days.

Kosan Biosciences Inc. is a biotechnology company using its proprietary technologies to develop drug candidates from an important class of natural product compounds known as polyketides. Polyketides are naturally made in very small amounts in microorganisms and are structurally complex and difficult to make or modify by chemical means. The company has developed technologies to manipulate the natural process by which polyketides are made. These technologies give the company the ability to create novel polyketides thereby providing a pipeline of potential drug candidates.Polyketides have been

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/3/2008 8:25 AM Buy
None
1.87 5.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/3/2007 9:25 AM Buy
None
4.99 9.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy